• Company
• New ATTR-CM drug Vyndamax to be prescribed at GHs
• by Eo, Yun-Ho Nov 2, 2021 05:54am

• Policy
• It is impossible to exclude PVA from domestic new drugs
• by Lee, Jeong-Hwan Nov 2, 2021 05:54am

• Policy
• 342 items unable for supply voluntarily withdraw listing
• by Lee, Hye-Kyung Nov 2, 2021 05:53am

• Policy
• Is the first generic release of the ADHD tx Concerta?
• by Lee, Tak-Sun Nov 2, 2021 05:53am

• Policy
• Generics for Jardiance have obtained generic for exclusivity
• by Lee, Tak-Sun Nov 2, 2021 05:53am

• Company
• AstraZeneca co-sells Qtern with Ildong Pharmaceutical
• by Eo, Yun-Ho Nov 1, 2021 05:56am

• Policy
• Redundancies in CDRD and PBAC roles in continuous dispute
• by Lee, Hye-Kyung Nov 1, 2021 05:56am

• Policy
• HIRA clarifies ‘Opdivo·Keytruda·Tecentriq’ eligibility
• by Lee, Hye-Kyung Nov 1, 2021 05:56am

• Company
• Hanmi & Ahn-Gook finally won the Galvus patent dispute
• by Kim, Jin-Gu Nov 1, 2021 05:55am

• Policy
• Concerns about the introduction of the Reference Price
• by Kim, Jung-Ju Nov 1, 2021 05:55am